DocGo Inc. — Director's Dealing 2023

Oct 4, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DocGo Inc. (DCGO)
CIK: 0001822359
Period of Report: 2023-10-02

Reporting Person: Tendler Ely D (Director, General Counsel and Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-10-02	Common Stock	M	10000	$1.59	Acquired	33088	Direct
2023-10-02	Common Stock	S	10000	$5.29	Disposed	23088	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-10-02	Options to purchase Common Stock	$1.59	M	10000	Disposed		Common Stock (10000)	Direct

Footnotes

F1: Exercise of options effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023 (the "10b5-1 Plan").

F2: Reflects 23,088 restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"), which will vest on December 15, 2023. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.

F3: Sale of shares effected pursuant to the 10b5-1 Plan.

F4: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $5.19 to $5.39. Upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F5: The options vested in three equal annual installments beginning on November 12, 2020 and expire January 1, 2030, subject to the terms of the Option Agreement entered into with Ambulnz Inc. and assumed by the Issuer on November 5, 2021.